The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Preimplantation Genetic Screening (PGS) Technology Market 2024 by Company, Regions, Type and Application, Forecast to 2028
Synopsis
The Preimplantation Genetic Screening (PGS) Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preimplantation Genetic Screening (PGS) Technology market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Maternity Centers & Fertility Clinics accounting for % of the Preimplantation Genetic Screening (PGS) Technology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-generation Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Preimplantation Genetic Screening (PGS) Technology include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Coopersurgical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preimplantation Genetic Screening (PGS) Technology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Market segment by Application, can be divided into
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Preimplantation Genetic Screening (PGS) Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Preimplantation Genetic Screening (PGS) Technology, with revenue, gross margin and global market share of Preimplantation Genetic Screening (PGS) Technology from 2019 to 2022.
Chapter 3, the Preimplantation Genetic Screening (PGS) Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Preimplantation Genetic Screening (PGS) Technology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Preimplantation Genetic Screening (PGS) Technology research findings and conclusion, appendix and data source.
Geographical Area
Global
The Preimplantation Genetic Screening (PGS) Technology market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our (Global Info Research) latest study, due to COVID-19 pandemic, the global Preimplantation Genetic Screening (PGS) Technology market size is estimated to be worth US$ million in 2021 and is forecast to a readjusted size of USD million by 2028 with a CAGR of % during review period. Maternity Centers & Fertility Clinics accounting for % of the Preimplantation Genetic Screening (PGS) Technology global market in 2021, is projected to value USD million by 2028, growing at a % CAGR in next six years. While Next-generation Sequencing segment is altered to a % CAGR between 2022 and 2028.
Global key companies of Preimplantation Genetic Screening (PGS) Technology include Illumina, Thermo Fisher Scientific, Agilent Technologies, PerkinElmer, and Coopersurgical, etc. In terms of revenue, the global top four players hold a share over % in 2021.
Market segmentation
Preimplantation Genetic Screening (PGS) Technology market is split by Type and by Application. For the period 2017-2028, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Next-generation Sequencing
Polymerase Chain Reaction
Fluorescence in Situ Hybridization
Comparative Genomic Hybridization
Single-nucleotide Polymorphism
Market segment by Application, can be divided into
Maternity Centers & Fertility Clinics
Hospitals
Research Laboratories & Academic Institutes
Others
Market segment by players, this report covers
Illumina
Thermo Fisher Scientific
Agilent Technologies
PerkinElmer
Coopersurgical
Natera
Takara Bio
Oxford Gene Technology
INVICTA
Genea
Progenesis
Igenomix
Reproductive Health and Wellness Center
Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Preimplantation Genetic Screening (PGS) Technology product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Preimplantation Genetic Screening (PGS) Technology, with revenue, gross margin and global market share of Preimplantation Genetic Screening (PGS) Technology from 2019 to 2022.
Chapter 3, the Preimplantation Genetic Screening (PGS) Technology competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with revenue and growth rate by Type, application, from 2017 to 2028.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2017 to 2022.and Preimplantation Genetic Screening (PGS) Technology market forecast, by regions, type and application, with revenue, from 2023 to 2028.
Chapter 11 and 12, to describe Preimplantation Genetic Screening (PGS) Technology research findings and conclusion, appendix and data source.
Geographical Area
Global
Index1 Market Overview
1.1 Product Overview and Scope of Preimplantation Genetic Screening (PGS) Technology
1.2 Classification of Preimplantation Genetic Screening (PGS) Technology by Type
1.2.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Market Size by Type: 2017 Versus 2021 Versus 2028
1.2.2 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2021
1.2.3 Next-generation Sequencing
1.2.4 Polymerase Chain Reaction
1.2.5 Fluorescence in Situ Hybridization
1.2.6 Comparative Genomic Hybridization
1.2.7 Single-nucleotide Polymorphism
1.3 Global Preimplantation Genetic Screening (PGS) Technology Market by Application
1.3.1 Overview: Global Preimplantation Genetic Screening (PGS) Technology Market Size by Application: 2017 Versus 2021 Versus 2028
1.3.2 Maternity Centers & Fertility Clinics
1.3.3 Hospitals
1.3.4 Research Laboratories & Academic Institutes
1.3.5 Others
1.4 Global Preimplantation Genetic Screening (PGS) Technology Market Size & Forecast
1.5 Global Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast by Region
1.5.1 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region: 2017 VS 2021 VS 2028
1.5.2 Global Preimplantation Genetic Screening (PGS) Technology Market Size by Region, (2017-2022)
1.5.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028)
1.5.4 Europe Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028)
1.5.5 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028)
1.5.6 South America Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028)
1.5.7 Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Market Size and Prospect (2017-2028)
1.6 Market Drivers, Restraints and Trends
1.6.1 Preimplantation Genetic Screening (PGS) Technology Market Drivers
1.6.2 Preimplantation Genetic Screening (PGS) Technology Market Restraints
1.6.3 Preimplantation Genetic Screening (PGS) Technology Trends Analysis
2 Company Profiles
2.1 Illumina
2.1.1 Illumina Details
2.1.2 Illumina Major Business
2.1.3 Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.1.4 Illumina Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.1.5 Illumina Recent Developments and Future Plans
2.2 Thermo Fisher Scientific
2.2.1 Thermo Fisher Scientific Details
2.2.2 Thermo Fisher Scientific Major Business
2.2.3 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.2.4 Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.2.5 Thermo Fisher Scientific Recent Developments and Future Plans
2.3 Agilent Technologies
2.3.1 Agilent Technologies Details
2.3.2 Agilent Technologies Major Business
2.3.3 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.3.4 Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.3.5 Agilent Technologies Recent Developments and Future Plans
2.4 PerkinElmer
2.4.1 PerkinElmer Details
2.4.2 PerkinElmer Major Business
2.4.3 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.4.4 PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.4.5 PerkinElmer Recent Developments and Future Plans
2.5 Coopersurgical
2.5.1 Coopersurgical Details
2.5.2 Coopersurgical Major Business
2.5.3 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.5.4 Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.5.5 Coopersurgical Recent Developments and Future Plans
2.6 Natera
2.6.1 Natera Details
2.6.2 Natera Major Business
2.6.3 Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.6.4 Natera Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.6.5 Natera Recent Developments and Future Plans
2.7 Takara Bio
2.7.1 Takara Bio Details
2.7.2 Takara Bio Major Business
2.7.3 Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.7.4 Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.7.5 Takara Bio Recent Developments and Future Plans
2.8 Oxford Gene Technology
2.8.1 Oxford Gene Technology Details
2.8.2 Oxford Gene Technology Major Business
2.8.3 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.8.4 Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.8.5 Oxford Gene Technology Recent Developments and Future Plans
2.9 INVICTA
2.9.1 INVICTA Details
2.9.2 INVICTA Major Business
2.9.3 INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.9.4 INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.9.5 INVICTA Recent Developments and Future Plans
2.10 Genea
2.10.1 Genea Details
2.10.2 Genea Major Business
2.10.3 Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.10.4 Genea Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.10.5 Genea Recent Developments and Future Plans
2.11 Progenesis
2.11.1 Progenesis Details
2.11.2 Progenesis Major Business
2.11.3 Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.11.4 Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.11.5 Progenesis Recent Developments and Future Plans
2.12 Igenomix
2.12.1 Igenomix Details
2.12.2 Igenomix Major Business
2.12.3 Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.12.4 Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.12.5 Igenomix Recent Developments and Future Plans
2.13 Reproductive Health and Wellness Center
2.13.1 Reproductive Health and Wellness Center Details
2.13.2 Reproductive Health and Wellness Center Major Business
2.13.3 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions
2.13.4 Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue, Gross Margin and Market Share (2019, 2020, 2021, and 2022)
2.13.5 Reproductive Health and Wellness Center Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Share by Players (2019, 2020, 2021, and 2022)
3.2 Market Concentration Rate
3.2.1 Top 3 Preimplantation Genetic Screening (PGS) Technology Players Market Share in 2021
3.2.2 Top 10 Preimplantation Genetic Screening (PGS) Technology Players Market Share in 2021
3.2.3 Market Competition Trend
3.3 Preimplantation Genetic Screening (PGS) Technology Players Head Office, Products and Services Provided
3.4 Preimplantation Genetic Screening (PGS) Technology Mergers & Acquisitions
3.5 Preimplantation Genetic Screening (PGS) Technology New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue and Market Share by Type (2017-2022)
4.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Type (2023-2028)
5 Market Size Segment by Application
5.1 Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application (2017-2022)
5.2 Global Preimplantation Genetic Screening (PGS) Technology Market Forecast by Application (2023-2028)
6 North America by Country, by Type, and by Application
6.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028)
6.2 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028)
6.3 North America Preimplantation Genetic Screening (PGS) Technology Market Size by Country
6.3.1 North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028)
6.3.2 United States Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
6.3.3 Canada Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
6.3.4 Mexico Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
7 Europe by Country, by Type, and by Application
7.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028)
7.2 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028)
7.3 Europe Preimplantation Genetic Screening (PGS) Technology Market Size by Country
7.3.1 Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028)
7.3.2 Germany Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
7.3.3 France Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
7.3.4 United Kingdom Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
7.3.5 Russia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
7.3.6 Italy Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028)
8.2 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028)
8.3 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Market Size by Region
8.3.1 Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2017-2028)
8.3.2 China Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
8.3.3 Japan Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
8.3.4 South Korea Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
8.3.5 India Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
8.3.6 Southeast Asia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
8.3.7 Australia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
9 South America by Country, by Type, and by Application
9.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028)
9.2 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028)
9.3 South America Preimplantation Genetic Screening (PGS) Technology Market Size by Country
9.3.1 South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028)
9.3.2 Brazil Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
9.3.3 Argentina Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2028)
10.2 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2028)
10.3 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Market Size by Country
10.3.1 Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2028)
10.3.2 Turkey Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
10.3.3 Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
10.3.4 UAE Preimplantation Genetic Screening (PGS) Technology Market Size and Forecast (2017-2028)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer
List of TablesList of Tables
Table 1. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Type, (USD Million), 2017 VS 2021 VS 2028
Table 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application, (USD Million), 2017 VS 2021 VS 2028
Table 3. Global Market Preimplantation Genetic Screening (PGS) Technology Revenue (Million USD) Comparison by Region (2017 VS 2021 VS 2028)
Table 4. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Region (2017-2022)
Table 5. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2023-2028)
Table 6. Illumina Corporate Information, Head Office, and Major Competitors
Table 7. Illumina Major Business
Table 8. Illumina Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 9. Illumina Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 10. Thermo Fisher Scientific Corporate Information, Head Office, and Major Competitors
Table 11. Thermo Fisher Scientific Major Business
Table 12. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 13. Thermo Fisher Scientific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 14. Agilent Technologies Corporate Information, Head Office, and Major Competitors
Table 15. Agilent Technologies Major Business
Table 16. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 17. Agilent Technologies Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 18. PerkinElmer Corporate Information, Head Office, and Major Competitors
Table 19. PerkinElmer Major Business
Table 20. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 21. PerkinElmer Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 22. Coopersurgical Corporate Information, Head Office, and Major Competitors
Table 23. Coopersurgical Major Business
Table 24. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 25. Coopersurgical Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 26. Natera Corporate Information, Head Office, and Major Competitors
Table 27. Natera Major Business
Table 28. Natera Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 29. Natera Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 30. Takara Bio Corporate Information, Head Office, and Major Competitors
Table 31. Takara Bio Major Business
Table 32. Takara Bio Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 33. Takara Bio Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 34. Oxford Gene Technology Corporate Information, Head Office, and Major Competitors
Table 35. Oxford Gene Technology Major Business
Table 36. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 37. Oxford Gene Technology Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 38. INVICTA Corporate Information, Head Office, and Major Competitors
Table 39. INVICTA Major Business
Table 40. INVICTA Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 41. INVICTA Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 42. Genea Corporate Information, Head Office, and Major Competitors
Table 43. Genea Major Business
Table 44. Genea Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 45. Genea Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 46. Progenesis Corporate Information, Head Office, and Major Competitors
Table 47. Progenesis Major Business
Table 48. Progenesis Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 49. Progenesis Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 50. Igenomix Corporate Information, Head Office, and Major Competitors
Table 51. Igenomix Major Business
Table 52. Igenomix Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 53. Igenomix Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 54. Reproductive Health and Wellness Center Corporate Information, Head Office, and Major Competitors
Table 55. Reproductive Health and Wellness Center Major Business
Table 56. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Product and Solutions
Table 57. Reproductive Health and Wellness Center Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million), Gross Margin and Market Share (2019, 2020, 2021, and 2022)
Table 58. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Players (2019, 2020, 2021, and 2022)
Table 59. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players (2019, 2020, 2021, and 2022)
Table 60. Breakdown of Preimplantation Genetic Screening (PGS) Technology by Company Type (Tier 1, Tier 2 and Tier 3)
Table 61. Preimplantation Genetic Screening (PGS) Technology Players Head Office, Products and Services Provided
Table 62. Preimplantation Genetic Screening (PGS) Technology Mergers & Acquisitions in the Past Five Years
Table 63. Preimplantation Genetic Screening (PGS) Technology New Entrants and Expansion Plans
Table 64. Global Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) by Type (2017-2022)
Table 65. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type (2017-2022)
Table 66. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Type (2023-2028)
Table 67. Global Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022)
Table 68. Global Preimplantation Genetic Screening (PGS) Technology Revenue Forecast by Application (2023-2028)
Table 69. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million)
Table 70. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million)
Table 71. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million)
Table 72. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million)
Table 73. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million)
Table 74. North America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million)
Table 75. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million)
Table 76. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million)
Table 77. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million)
Table 78. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million)
Table 79. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million)
Table 80. Europe Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million)
Table 81. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million)
Table 82. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million)
Table 83. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million)
Table 84. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million)
Table 85. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2017-2022) & (USD Million)
Table 86. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue by Region (2023-2028) & (USD Million)
Table 87. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million)
Table 88. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million)
Table 89. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million)
Table 90. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million)
Table 91. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million)
Table 92. South America Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million)
Table 93. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2017-2022) & (USD Million)
Table 94. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Type (2023-2028) & (USD Million)
Table 95. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2017-2022) & (USD Million)
Table 96. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Application (2023-2028) & (USD Million)
Table 97. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2017-2022) & (USD Million)
Table 98. Middle East & Africa Preimplantation Genetic Screening (PGS) Technology Revenue by Country (2023-2028) & (USD Million)
List of Figures
Figure 1. Preimplantation Genetic Screening (PGS) Technology Picture
Figure 2. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Type in 2021
Figure 3. Next-generation Sequencing
Figure 4. Polymerase Chain Reaction
Figure 5. Fluorescence in Situ Hybridization
Figure 6. Comparative Genomic Hybridization
Figure 7. Single-nucleotide Polymorphism
Figure 8. Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Application in 2021
Figure 9. Maternity Centers & Fertility Clinics Picture
Figure 10. Hospitals Picture
Figure 11. Research Laboratories & Academic Institutes Picture
Figure 12. Others Picture
Figure 13. Global Preimplantation Genetic Screening (PGS) Technology Market Size, (USD Million): 2017 VS 2021 VS 2028
Figure 14. Global Preimplantation Genetic Screening (PGS) Technology Revenue and Forecast (2017-2028) & (USD Million)
Figure 15. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2017-2028)
Figure 16. Global Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region in 2021
Figure 17. North America Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 18. Europe Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 19. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 20. South America Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 21. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue (USD Million) and Growth Rate (2017-2028)
Figure 22. Preimplantation Genetic Screening (PGS) Technology Market Drivers
Figure 23. Preimplantation Genetic Screening (PGS) Technology Market Restraints
Figure 24. Preimplantation Genetic Screening (PGS) Technology Market Trends
Figure 25. Illumina Recent Developments and Future Plans
Figure 26. Thermo Fisher Scientific Recent Developments and Future Plans
Figure 27. Agilent Technologies Recent Developments and Future Plans
Figure 28. PerkinElmer Recent Developments and Future Plans
Figure 29. Coopersurgical Recent Developments and Future Plans
Figure 30. Natera Recent Developments and Future Plans
Figure 31. Takara Bio Recent Developments and Future Plans
Figure 32. Oxford Gene Technology Recent Developments and Future Plans
Figure 33. INVICTA Recent Developments and Future Plans
Figure 34. Genea Recent Developments and Future Plans
Figure 35. Progenesis Recent Developments and Future Plans
Figure 36. Igenomix Recent Developments and Future Plans
Figure 37. Reproductive Health and Wellness Center Recent Developments and Future Plans
Figure 38. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Players in 2021
Figure 39. Preimplantation Genetic Screening (PGS) Technology Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2021
Figure 40. Global Top 3 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2021
Figure 41. Global Top 10 Players Preimplantation Genetic Screening (PGS) Technology Revenue Market Share in 2021
Figure 42. Key Players Market Share Trend (Top 3 Market Share: 2020 VS 2021 VS 2022)
Figure 43. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Type in 2021
Figure 44. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Type (2023-2028)
Figure 45. Global Preimplantation Genetic Screening (PGS) Technology Revenue Share by Application in 2021
Figure 46. Global Preimplantation Genetic Screening (PGS) Technology Market Share Forecast by Application (2023-2028)
Figure 47. North America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028)
Figure 48. North America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028)
Figure 49. North America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028)
Figure 50. United States Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 51. Canada Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 52. Mexico Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 53. Europe Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028)
Figure 54. Europe Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028)
Figure 55. Europe Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028)
Figure 56. Germany Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 57. France Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 58. United Kingdom Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 59. Russia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 60. Italy Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 61. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028)
Figure 62. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028)
Figure 63. Asia-Pacific Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Region (2017-2028)
Figure 64. China Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 65. Japan Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 66. South Korea Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 67. India Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 68. Southeast Asia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 69. Australia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 70. South America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028)
Figure 71. South America Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028)
Figure 72. South America Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028)
Figure 73. Brazil Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 74. Argentina Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 75. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Type (2017-2028)
Figure 76. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Sales Market Share by Application (2017-2028)
Figure 77. Middle East and Africa Preimplantation Genetic Screening (PGS) Technology Revenue Market Share by Country (2017-2028)
Figure 78. Turkey Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 79. Saudi Arabia Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 80. UAE Preimplantation Genetic Screening (PGS) Technology Revenue and Growth Rate (2017-2028) & (USD Million)
Figure 81. Methodology
Figure 82. Research Process and Data Source
Published By : GlobalInfoResearch
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
